PolyPid (PYPD) Stock Analysis

PolyPid (PYPD) is a publicly traded company in the HEALTHCARE sector. It trades at $4.87, carries a market capitalization of $97.21M. This page summarizes the public market data, fundamentals, and frequently asked questions for PYPD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.87
• Market Cap: $97.21M
• EPS: $-1.74
• 52-Week High: $5.20
• 52-Week Low: $2.77

Market Sentiment

PolyPid currently has a Bullish sentiment score of 0.31.

About PolyPid

PolyPid Ltd. is a pioneering biopharmaceutical company based in Petah Tikva, Israel, dedicated to the development of innovative therapies through its proprietary Polymer Lipid Encapsulation Matrix (PLEX) technology. With a robust pipeline targeting local infections and enhancing surgical outcomes, PolyPid addresses significant unmet medical needs in the healthcare sector. Positioned within a dynamic biotech ecosystem, the company is well-placed to pursue strategic collaborations and drive adv...

GNG Research Analysis

GNG Research scores PolyPid (PYPD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PYPD.

Frequently Asked Questions

Does PYPD pay dividends?

PolyPid (PYPD) does not currently pay a regular dividend.

What is PYPD's market cap?

PolyPid (PYPD) has a market capitalization of $97.21M with a current stock price of $4.87.